Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes

Eur J Pharmacol. 1994 Jun 23;259(1):15-20. doi: 10.1016/0014-2999(94)90151-1.

Abstract

The influence of IPD-1151T (suplatast-tosilate) on murine mast cell induction was examined by in vitro cell culture. Splenocytes from BALB/c mice suspended in RPMI-1640 medium supplemented with interleukin-3 were cultured in the presence or absence of IPD-1151T. Half of the total volume of the medium was changed every 4-5 days. The number of mast cells increased with culture time and reached a peak on the 16th day when the cells were cultured without IPD-1151T. However, the growth of mast cells from the splenocyte culture was dose dependently inhibited by IPD-1151T. Furthermore, IPD-1151T inhibited the proliferation of mast cell progenitor cells, IC-2, but not that of splenocytes or mature mast cells.

MeSH terms

  • Animals
  • Arylsulfonates / pharmacokinetics
  • Arylsulfonates / pharmacology*
  • Cell Division / drug effects
  • Cells, Cultured
  • Cromolyn Sodium / pharmacology
  • Histamine Antagonists / pharmacology*
  • Male
  • Mast Cells / drug effects*
  • Mice
  • Mice, Inbred BALB C
  • Spleen / cytology
  • Sulfonium Compounds / pharmacokinetics
  • Sulfonium Compounds / pharmacology*

Substances

  • Arylsulfonates
  • Histamine Antagonists
  • Sulfonium Compounds
  • suplatast tosilate
  • Cromolyn Sodium